The minimally invasive surgery robot market size is projected to reach US$ 29.13 billion by 2031 from US$ 11.16 billion in 2024. The market is expected to register a CAGR of 14.8% during 2025–2031. AI-driven surgical assistance is emerging as a significant trend in the minimally invasive surgery robot market.
The minimally invasive surgery robot market is witnessing substantial growth due to technological advancements that have significantly enhanced the capabilities of surgical robots, incorporating features such as high-definition 3D visualization, augmented reality, and real-time data analytics, which improve surgical precision and outcomes. The rising prevalence of chronic diseases such as cancer, cardiovascular conditions, and obesity has increased the demand for surgical interventions, further propelling market growth. Additionally, the aging global population is contributing to a higher volume of surgical procedures, thereby expanding the need for advanced surgical technologies. Patient preference for minimally invasive procedures, which offer benefits such as reduced postoperative pain and quicker recovery times, is positively influencing the market. These factors collectively contribute to the sustained expansion of the minimally invasive surgery robot market.
The global minimally invasive surgery robot market is accelerating owing to the rising prevalence of chronic diseases, growing technological advancements in robotics, and increasing consumer awareness of the benefits of minimally invasive procedures. Key players in the market, including Intuitive Surgical, Medtronic, and Stryker, are continuously innovating to meet the rising demand for minimally invasive surgical solutions. Moreover, there is increasing adoption of robotic-assisted surgeries, owing to their reduced recovery times, minimized scarring, and enhanced surgical precision, as well as the integration of artificial intelligence and machine learning into robotic systems. North America led the market in 2024 due to high healthcare spending and early adoption of robotic systems. Asia Pacific is anticipated to witness the fastest growth, fueled by increasing healthcare investments and rapidly developing infrastructure.
The demand for precise and minimally invasive procedures across neurosurgery, ophthalmology, urology, cardiovascular, reconstructive, and other surgeries is increasing. Microsurgery is a complex surgical procedure that is carried out with the help of special instruments and microscopes to treat minute structures such as blood vessels, nerves, or small organs. These surgeries are prevalent in ophthalmology, neurosurgery, ENT (ear, nose, and throat), reconstructive surgery, and vascular surgery.
As per the Global Neurosurgery study, annually, ~22.6 million neurosurgical consultations occur worldwide, of which 13.8 million cases require operative intervention. According to data from the American Society of Plastic Surgeons, in 2023, a total of 157,740 breast reconstruction procedures were performed in the US, marking a notable increase from the 137,808 procedures recorded in 2020. As per the Cleveland Clinic, in the US, vascular surgeons perform over 100,000 surgeries and procedures annually. The most common types of vascular surgeries involve treating peripheral artery disease (PAD). Moreover, ~20 million cataract surgeries are performed each year throughout the world, with ~3.7 million surgeries in the US.
Therefore, the demand by surgeons for enhanced visualization and scaling down motion in such a rising number of complex microsurgeries is propelling the use of robotics in developed countries and is likely to drive the growth of the minimally invasive surgery robot market in the coming years.
Emerging economies present a substantial opportunity for the expansion of minimally invasive surgery (MIS) robots. These regions are experiencing growing advancements in healthcare infrastructure and increasing government investment in advanced medical technologies.
India presents a significant growth opportunity for minimally invasive surgical robots due to its large surgical burden and rapidly expanding private healthcare sector. Apollo Hospitals, Fortis Healthcare, and others are increasingly adopting advanced robotic platforms such as the da Vinci Surgical System and Versius to enhance surgical precision and improve patient outcomes. Additionally, the Indian government is actively supporting the healthcare technology ecosystem through public-private partnerships and the development of medical technology parks. These initiatives aim to improve access to cutting-edge surgical tools beyond metropolitan centers, creating a viable pathway for the adoption of robotic surgery in tier-2 and tier-3 cities. This rising demand for minimally invasive surgeries, growing investments in the private sector, and an increasing number of favorable policies are expected to offer a high-potential market for MIS robots in emerging countries.
Southeast Asian countries such as Vietnam, the Philippines, and Indonesia are observing a growing population and a rising incidence of chronic diseases. As healthcare systems in the region face increasing demand for quality surgical care, governments are boosting healthcare spending and prioritizing the modernization of medical infrastructure. This creates a conducive environment for the adoption of robotic-assisted surgery. Furthermore, international medical device companies are entering these markets through strategic partnerships with local hospitals and by launching subsidized pilot projects to demonstrate the clinical and economic benefits of robotic platforms. These initiatives are helping to build awareness, expand training capacity, and lay the groundwork for the long-term adoption of MIS technologies in the region. Thus, untapped markets in emerging economies present significant growth opportunities for MIS robots, driven by rising healthcare demand, improving infrastructure, and increasing willingness to adopt advanced surgical technologies, thereby creating lucrative opportunities for market growth during the forecast period.
Key segments that are the foundation of minimally invasive surgery robot market analysis are product and services, application, and end use.
The geographic scope of the minimally invasive surgery robot market report is divided into five regions: North America, Asia Pacific, Europe, the Middle East and Africa, and South and Central America.
North America held a significant share of the market in 2024. A primary catalyst is the region's advanced healthcare infrastructure and substantial healthcare expenditure. Innovations in robotic systems, such as the integration of artificial intelligence, machine learning, and augmented reality, have enhanced the precision and capabilities of surgical robots. These advancements enable surgeons to perform complex procedures with greater accuracy and efficiency, contributing to the adoption of MIS robots in various medical specialties. North America, particularly the US, has high healthcare expenditures and favorable reimbursement policies for robotic-assisted surgeries. These factors incentivize hospitals and surgical centers to invest in advanced robotic technologies, facilitating the widespread adoption of MIS robots. Major medical robotics companies, such as Intuitive Surgical, Medtronic, and Stryker, have a strong presence in North America. Their ongoing research and development efforts, along with collaborations with healthcare institutions, have accelerated the introduction and adoption of MIS robotic systems in the region.
The regional trends and factors influencing the Minimally Invasive Surgery Robot Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Minimally Invasive Surgery Robot Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ 11.16 Billion |
| Market Size by 2031 | US$ 29.13 Billion |
| Global CAGR (2025 - 2031) | 14.8% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Product and Services
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Minimally Invasive Surgery Robot Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Minimally Invasive Surgery Robot Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The minimally invasive surgery robot market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A key development in the market is listed below:
The "Minimally Invasive Surgery Robot Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
The market is estimated to register a CAGR of 14.8% during the forecast period.
The market is expected to reach US$ 29.13 billion by 2031.
Johnson and Johnson; Stryker Corp.; Medtronic Plc; Intuitive Surgical Inc.; Asensus Surgical Inc.; Smith and Nephew Plc.; Zimmer Biomet Holdings Inc.; CMR Surgical Ltd; Moon Surgical; and CUREXO, INC are among the key players operating in the minimally invasive surgery robot market.
The growing number of microsurgeries and the growing prevalence of chronic diseases contribute to market growth.
North America dominated the market in 2024.